Cargando…

936. Antimicrobial Stewardship Assessments in De-labeling Beta-lactam Allergies

BACKGROUND: Unnecessary use of broad-spectrum antibiotics due to false antibiotic allergy labels leads to an increase in drug resistant and health care associated infections. Therefore, allergy assessments to de-label patients not truly allergic is an important antimicrobial stewardship (AMS) tool....

Descripción completa

Detalles Bibliográficos
Autores principales:	Fahmy, Nicole, Morado, Faiza, Nanda, Neha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752285/ http://dx.doi.org/10.1093/ofid/ofac492.780

Ejemplares similares

1257. The Impact of Communication Type on Acceptance Rates of Antimicrobial Stewardship Interventions
por: Morado, Faiza, et al.
Publicado: (2023)

Analysis of a beta-lactam allergy assessment protocol challenging diverse reported allergies managed by an antimicrobial stewardship program
por: Jacobs, Max W., et al.
Publicado: (2023)

1237. Inpatients with a beta-lactam antibiotic allergy label (BAAL) and unrevealed tolerance: A prevalence study aimed to prioritize non-invasive delabeling for antimicrobial stewardship programs
por: Dickens, Michael, et al.
Publicado: (2023)

Grading the Impact of a Standardized Β Lactam Antibiotic Allergy Assessment Protocol for Treatment Decisions: An Antimicrobial Stewardship Target
por: Hernandez, Kanizeh, et al.
Publicado: (2017)

1776. Overcoming barriers and expanding an existing Antimicrobial Stewardship Program: Allergy Collaboration to de-label Penicillin allergy
por: Adenew, Ayne, et al.
Publicado: (2022)

1805. Safety Outcomes Following Beta-Lactam use in Patients with a Documented Beta-Lactam Allergy
por: Rampersad, Daniel, et al.
Publicado: (2022)

1462. Analysis of Clindamycin and Vancomycin Use and Reported Beta Lactam Allergy in Procedural Antimicrobial Prophylaxis
por: Veach, Lisa A, et al.
Publicado: (2023)

516. Evaluation of COVID-19 Monoclonal Antibody Therapies for the Treatment of Non-hospitalized Patients with COVID-19
por: Morado, Faiza, et al.
Publicado: (2021)

1181. Evaluation of the Safety of a Beta-Lactam Allergy Protocol
por: Sakowski, Alexandra K, et al.
Publicado: (2023)

162. Assessment of Beta-lactam Allergies as Rationale for Receipt of Vancomycin for Surgical Prophylaxis
por: Tucker, Kendall J, et al.
Publicado: (2020)

1182. Impact of Penicillin Allergy Focused Antimicrobial Stewardship Interventions on Antimicrobial Use and Allergy Documentation - Optimizing Allergy Prescribing Alerts and Pharmacy Allergy Assessments
por: Stephens, Emily, et al.
Publicado: (2023)

1186. Beta is Better: Impact of a Multifaceted Stewardship Initiative on the Sequential Timing of Beta-Lactam Administration
por: Deri, Connor R, et al.
Publicado: (2023)

1792. Assessing Outcomes of Antimicrobial Stewardship Interventions Along With a Hospital-Wide β-Lactam Allergy Guideline Through Aztreonam Use: A 5-Year Observation
por: Wang, Sheila K, et al.
Publicado: (2018)

269. De-Labeling of Allergies to Β-Lactam Antibiotics (De-LABeL) Program: Development and Pilot of an Inpatient Pediatric Program
por: Wong, Jacqueline, et al.
Publicado: (2018)

An Antimicrobial Stewardship Initiative to Evaluate Penicillin Allergy Labels in Spinal Cord Injury and Long-Term Care Patients
por: Hall, Toni, et al.
Publicado: (2017)

1131. Prevalence and Characteristics of Non-β-Lactam Allergy Labeling at a Children’s Hospital
por: Miceli, Amanda, et al.
Publicado: (2019)

Genetic associations in beta-lactam allergy
por: Gueant, Jean-Louis, et al.
Publicado: (2014)

993. Pharmacist-driven Penicillin Allergy Assessment in the Emergency Department – Antimicrobial Stewardship at the Point of Prescription
por: Campbell, Samantha, et al.
Publicado: (2019)

Beta-lactam allergy labeling in intensive care units: An observational, retrospective study
por: Leone, Marc, et al.
Publicado: (2021)

1267. Implementation and Outcomes of Beta-lactam Allergy Management Protocol at a Comprehensive Cancer Center
por: Khalak, Sohanabanu, et al.
Publicado: (2023)

66. Improving Antimicrobial Stewardship through Allergy Testing Referrals
por: Smith, Clarissa, et al.
Publicado: (2021)

2543. Implementation of a Fellow-Driven Β-Lactam Allergy De-Labeling Initiative on an Inpatient ID Consult Service
por: Mulliken, Jennifer S, et al.
Publicado: (2019)

Approach for delabeling beta-lactam allergy in children
por: Sáenz de Santa María, R., et al.
Publicado: (2023)

1221. Non-severe, non-immune mediated intolerances: simple targets for direct non-invasive delabeling opportunities of beta-lactam antibiotic allergy labels (BAAL)
por: Polisetty, Radhika S, et al.
Publicado: (2023)

884. Evaluation of Surgical Site Infections in Solid Organ Transplant Recipients with Beta-Lactam Allergies
por: Mowrer, Clayton, et al.
Publicado: (2020)

906. Surgical Site Infections in Children with Beta-Lactam Allergy: A Matched Cohort Study
por: Huang, Felicia Scaggs, et al.
Publicado: (2020)

994. Effect on Β-lactam Usage Following Implementation of Clinical Pharmacy Services to Improve Β-lactam Allergy History Documentation
por: Harrington, Nicole, et al.
Publicado: (2019)

239. Outcomes Associated with Empiric Aztreonam Use Compared to Anti-Pseudomonal β-lactams in Patients with Sepsis: An Opportunity for Allergy Stewardship
por: Jaffa, Rupal K, et al.
Publicado: (2020)

Beta-lactam allergy in Chinese patients and factors predicting genuine allergy
por: Li, Philip Hei, et al.
Publicado: (2019)

1795. Safety Outcomes of the Use of β-Lactam Therapy in Patients With Documented β-Lactam Allergy
por: Bjork, Lauren
Publicado: (2018)

1957. Impact of β-Lactam Antibiotic Allergy on Antimicrobial Use, Clinical Outcomes, and Costs for Hospitalized Children
por: Jones, Trahern Wallace, et al.
Publicado: (2019)

322. Improving Assessment of Beta-Lactam Allergies by Embedding a Questionnaire in Best Practice Advisory Alerts Across a Large Health System
por: Boger, Michael S, et al.
Publicado: (2023)

Drug allergy in children: focus on beta-lactams and NSAIDs
por: Cravidi, Claudio, et al.
Publicado: (2020)

Suspected allergy to Beta-Lactam antibiotics: An infectiological perspective
por: Sunderkötter, Cord
Publicado: (2022)

44. Antibiotic Class-Based Distribution and Analysis of Reported Beta-Lactam Allergies amongst Hospitalized Patients
por: Hornak, Joseph Patrik, et al.
Publicado: (2020)

Investigation into patients with suspected adverse reactions to beta-lactams carried out by the allergy unit of Rio de Janeiro General Policlinic
por: Loyola, Flavia Carvalho Loyola
Publicado: (2015)

107. Impact of Penicillin Allergy Assessment During Pre-Anesthesia Testing (PAT) on Beta-Lactam Surgical Prophylaxis in Bariatric Surgery Patients
por: Hitchins, Maggie, et al.
Publicado: (2021)

1837. Evaluation of Disparities in Beta-Lactam Allergies and Subsequent Antibiotic Use in Outpatients with Acute Bacterial Skin and Skin Structure Infections
por: Hall, Ronald G, et al.
Publicado: (2023)

Applying Diagnostic Stewardship to Proactively Optimize the Management of Urinary Tract Infections
por: Morado, Faiza, et al.
Publicado: (2022)

1003. Impact of a Standardized Pharmacist-led Β-lactam Allergy Interview on the Quality of Allergy Documentation
por: Nguyen, Cynthia T, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_s261p61p4hrf0s99dc1c5km40k